289 related articles for article (PubMed ID: 7841600)
1. Antiphospholipid antibodies and thrombosis.
Brighton TA; Chesterman CN
Baillieres Clin Haematol; 1994 Sep; 7(3):541-57. PubMed ID: 7841600
[TBL] [Abstract][Full Text] [Related]
2. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid antibodies: specificity and pathophysiology.
de Groot PG; Oosting JD; Derksen RH
Baillieres Clin Haematol; 1993 Sep; 6(3):691-709. PubMed ID: 8025348
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies.
Roubey RA
Blood; 1994 Nov; 84(9):2854-67. PubMed ID: 7949161
[No Abstract] [Full Text] [Related]
5. Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects.
Vázquez-Mellado J; Llorente L; Richaud-Patin Y; Alarcón-Segovia D
J Autoimmun; 1994 Jun; 7(3):335-48. PubMed ID: 7916907
[TBL] [Abstract][Full Text] [Related]
6. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
7. Recent insights into antiphospholipid antibody-mediated thrombosis.
Field SL; Brighton TA; McNeil HP; Chesterman CN
Baillieres Best Pract Res Clin Haematol; 1999 Sep; 12(3):407-22. PubMed ID: 10856978
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway.
Yasuda S; Bohgaki M; Atsumi T; Koike T
Immunobiology; 2005; 210(10):775-80. PubMed ID: 16325497
[TBL] [Abstract][Full Text] [Related]
9. Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome.
Teixidó M; Font J; Reverter JC; Cervera R; Tàssies D; Ingelmo M; Escolar G; Ordinas A
Br J Rheumatol; 1997 Jan; 36(1):113-6. PubMed ID: 9117149
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibodies in children without and in adults with and without thrombophilia.
Siemens HJ; Gutsche S; Brückner S; Bucsky P; Katus HA
Thromb Res; 2000 May; 98(4):241-7. PubMed ID: 10822070
[TBL] [Abstract][Full Text] [Related]
11. Anticardiolipin antibodies block the inhibition by beta 2-glycoprotein I of the factor Xa generating activity of platelets.
Shi W; Chong BH; Hogg PJ; Chesterman CN
Thromb Haemost; 1993 Aug; 70(2):342-5. PubMed ID: 8236146
[TBL] [Abstract][Full Text] [Related]
12. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins.
Bertolaccini ML; Hughes GR; Khamashta MA
Clin Lab; 2004; 50(11-12):653-65. PubMed ID: 15575307
[TBL] [Abstract][Full Text] [Related]
13. [Assay principles of antiphospholipid antibodies and heterogeneity of the antibodies].
Matsuura E
Rinsho Byori; 2000 Apr; 48(4):317-22. PubMed ID: 10810876
[TBL] [Abstract][Full Text] [Related]
14. [Antiphospholipid antibodies and thrombosis: the putative mechanisms of hypercoagulable state in patients with anticardiolipin antibody].
Ieko M
Rinsho Byori; 2000 Apr; 48(4):293-300. PubMed ID: 10810873
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of antiphospholipid antibodies].
Atsumi T; Koike T
Rinsho Byori; 1998 Apr; 46(4):297-302. PubMed ID: 9594618
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
[TBL] [Abstract][Full Text] [Related]
17. [Antiphospholipid-protein antibodies. Effects on the endothelium-platelet interaction].
Forastiero RR; Martinuzzo ME; Carreras LO
Sangre (Barc); 1999 Jun; 44(3):223-30. PubMed ID: 10481585
[No Abstract] [Full Text] [Related]
18. Pathogenic role of antiprotein-phospholipid antibodies.
Carreras LO; Forastiero RR
Haemostasis; 1996 Oct; 26 Suppl 4():340-57. PubMed ID: 8979139
[TBL] [Abstract][Full Text] [Related]
19. beta 2 Glycoprotein I--a key player in the antiphospholipid syndrome.
Lutters BC; de Groot PG; Derksen RH
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):958-62. PubMed ID: 12455190
[No Abstract] [Full Text] [Related]
20. Antiphospholipid antibody profile: implications for the evaluation and management of patients.
Tincani A; Andreoli L; Casu C; Cattaneo R; Meroni P
Lupus; 2010 Apr; 19(4):432-5. PubMed ID: 20353983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
